Reactive oxygen species in vascular endothelial cell motility. Roles of NAD(P)H oxidase and Rac1

被引:89
作者
Moldovan, Leni
Mythreye, Karthikeyan
Goldschmidt-Clermont, Pascal J.
Satterwhite, Lisa L.
机构
[1] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[2] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA
[3] Univ Miami, Leonard M Miller Sch Med, Miami, FL 33101 USA
关键词
redox signalling; endothelial function; NADPH oxidase; oxygen radicals; cytoskeleton;
D O I
10.1016/j.cardiores.2006.05.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reactive oxygen species (ROS) are acknowledged generally to be multi-faceted regulators of cellular functions that trigger various pathological states when present chronically or transiently at non-physiologically high levels. Here we focus on the physiological involvement of ROS in cellular motility, with special emphasis on endothelial cells (EC). An important source of ROS within EC is the non-phagocytic NAD(P)H oxidase, and the small GTPase Rac1 plays a central role in activating this complex. Rac1 is one of the three Rho-family molecules (Rac, Rho and Cdc42) involved in the control of the actin cytoskeleton in response to various signals. In this review we examine the evidence linking ROS production, Rac1 activation and actin organization to EC motility, considering mechanisms for direct interaction of ROS and actin and the effects of ROS on proteins that regulate the actin cytoskeleton. The accumulated evidence suggests that ROS are important regulators of the actin cytoskeletal dynamics and cellular motility, and more in-depth studies are needed to understand the underlying mechanisms. (c) 2006 European Society of Cardiology. Published by Elsevier B.V All rights reserved.
引用
收藏
页码:236 / 246
页数:11
相关论文
共 157 条
[31]   Angiotensin II inhibits endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability [J].
Desideri, G ;
Bravi, MC ;
Tucci, M ;
Croce, G ;
Marinucci, MC ;
Santucci, A ;
Alesse, E ;
Ferri, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (07) :1218-1223
[32]   INTERACTION OF RAC WITH P67(PHOX) AND REGULATION OF PHAGOCYTIC NADPH OXIDASE ACTIVITY [J].
DIEKMANN, D ;
ABO, A ;
JOHNSTON, C ;
SEGAL, AW ;
HALL, A .
SCIENCE, 1994, 265 (5171) :531-533
[33]   Actin polymerization machinery: the finish line of signaling networks, the starting point of cellular movement [J].
Disanza, A ;
Steffen, A ;
Hertzog, M ;
Frittoli, E ;
Rottner, K ;
Scita, G .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (09) :955-970
[34]   The S100A8/A9 protein as a partner for the cytosolic factors of NADPH oxidase activation in neutrophils [J].
Doussiere, J ;
Bouzidi, F ;
Vignais, PV .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (13) :3246-3255
[35]   Endothelin-1 induces NAD(P)H oxidase in human endothelial cells [J].
Duerrschmidt, N ;
Wippich, N ;
Goettsch, W ;
Broemme, HJ ;
Morawietz, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (03) :713-717
[36]   Direct oxidative modifications of signalling proteins in mammalian cells and their effects on apoptosis [J].
England, K ;
Cotter, TG .
REDOX REPORT, 2005, 10 (05) :237-245
[37]   Reactive oxygen species and signal transduction [J].
Finkel, T .
IUBMB LIFE, 2001, 52 (1-2) :3-6
[38]   Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes [J].
Fratelli, M ;
Demol, H ;
Puype, M ;
Casagrande, S ;
Eberini, I ;
Salmona, M ;
Bonetto, V ;
Mengozzi, M ;
Duffieux, F ;
Miclet, E ;
Bachi, A ;
Vandekerckhove, J ;
Gianazza, E ;
Ghezzi, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (06) :3505-3510
[39]   Redox regulation: A new challenge for pharmacology [J].
Frein, D ;
Schildknecht, S ;
Bachschmid, M ;
Ullrich, V .
BIOCHEMICAL PHARMACOLOGY, 2005, 70 (06) :811-823
[40]   Rho, Rac, Pak and angiogenesis: old roles and newly identified responsibilities in endothelial cells [J].
Fryer, BH ;
Field, J .
CANCER LETTERS, 2005, 229 (01) :13-23